GetTopicDetailResponse(id=d720298e08, topicName=ATTR-CM, introduction=ATTR-CM, content=null, image=null, comments=1, allHits=1141, url=https://h5.medsci.cn/topic?id=2987, type=1, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=91847, tagList=[TagDto(tagId=91847, tagName=ATTR-CM)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2269754, encodeId=79162269e547b, content=<a href='/topic/show?id=d720298e08' target=_blank style='color:#2F92EE;'>#ATTR-CM#</a> <a href='/topic/show?id=17cc126665a8' target=_blank style='color:#2F92EE;'>#OCC 2025#</a>, objectTitle=專訪賓建平教授：解析ATTR-CM治療前沿進展 | OCC 2025, objectType=article, longId=882920, objectId=367a88292074, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20250617/1750147588245_92910.png, objectUrl=/article/show_article.do?id=367a88292074, replyNumber=0, likeNumber=29, createdTime=2025-06-17, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=367a88292074, moduleTitle=專訪賓建平教授：解析ATTR-CM治療前沿進展 | OCC 2025, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=367a88292074)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2227610, encodeId=012a222e610f0, content=<a href='/topic/show?id=d720298e08' target=_blank style='color:#2F92EE;'>#ATTR-CM#</a>, objectTitle=監(jiān)測接受治療的ATTR-CM患者疾病進展的推薦測量工具, objectType=article, longId=844777, objectId=98f4844e77e2, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240925/1727241550719_8538692.jpg, objectUrl=/article/show_article.do?id=98f4844e77e2, replyNumber=0, likeNumber=35, createdTime=2024-09-25, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=98f4844e77e2, moduleTitle=監(jiān)測接受治療的ATTR-CM患者疾病進展的推薦測量工具, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=98f4844e77e2)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1741842, encodeId=29d11e418426b, content=<a href='/topic/show?id=d720298e08' target=_blank style='color:#2F92EE;'>#ATTR-CM#</a>, objectTitle=輝瑞的Vyndaqel首次在歐洲獲批用于治療淀粉樣變心肌病ATTR-CM, objectType=article, longId=188474, objectId=ccaa1884e403, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ccaa1884e403, replyNumber=0, likeNumber=109, createdTime=2020-05-19, rootId=0, userName=ms4657536712156177, userId=c44b34947164, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ccaa1884e403, moduleTitle=輝瑞的Vyndaqel首次在歐洲獲批用于治療淀粉樣變心肌病ATTR-CM, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=ccaa1884e403)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
